MetLife Investment Advisors LLC Has $130,000 Holdings in RTI Surgical Inc (RTIX)

Saturday, June 30 2018

MetLife Investment Advisors LLC Has $130,000 Holdings in RTI Surgical Inc (RTIX)

Posted by Susan Goodwin on Jun 30th, 2018 // No Comments
MetLife Investment Advisors LLC boosted its stake in shares of RTI Surgical Inc (NASDAQ:RTIX) by 245.9% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 28,338 shares of the medical equipment provider’s stock after acquiring an additional 20,146 shares during the quarter. MetLife Investment Advisors LLC’s holdings in RTI Surgical were worth $130,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently modified their holdings of RTIX. SG Americas Securities LLC bought a new stake in RTI Surgical during the fourth quarter worth approximately $113,000. Citadel Advisors LLC bought a new stake in RTI Surgical during the first quarter worth approximately $130,000. Mackay Shields LLC bought a new stake in RTI Surgical during the first quarter worth approximately $151,000. Goldman Sachs Group Inc. bought a new stake in RTI Surgical during the fourth quarter worth approximately $154,000. Finally, JPMorgan Chase & Co. increased its stake in RTI Surgical by 204.0% during the first quarter. JPMorgan Chase & Co. now owns 44,163 shares of the medical equipment provider’s stock worth $204,000 after acquiring an additional 29,634 shares during the last quarter. 67.57% of the stock is currently owned by institutional investors. Get RTI Surgical alerts:
Several research analysts have issued reports on RTIX shares. Zacks Investment Research lowered RTI Surgical from a “hold” rating to a “sell” rating in a research report on Tuesday, March 6th. BidaskClub lowered RTI Surgical from a “hold” rating to a “sell” rating in a research report on Wednesday, March 28th. Finally, Craig Hallum upgraded RTI Surgical from a “hold” rating to a “buy” rating in a research report on Friday, March 2nd. Shares of RTI Surgical opened at $4.60 on Friday, MarketBeat Ratings reports. RTI Surgical Inc has a 1 year low of $3.85 and a 1 year high of $6.00. The company has a market cap of $279.08 million, a price-to-earnings ratio of 92.00, a price-to-earnings-growth ratio of 2.93 and a beta of 1.59. The company has a quick ratio of 1.53, a current ratio of 3.81 and a debt-to-equity ratio of 0.31.
RTI Surgical (NASDAQ:RTIX) last announced its earnings results on Thursday, May 3rd. The medical equipment provider reported $0.01 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.01. RTI Surgical had a return on equity of 2.49% and a net margin of 2.57%. The business had revenue of $69.89 million during the quarter, compared to analyst estimates of $68.70 million. analysts anticipate that RTI Surgical Inc will post 0.1 EPS for the current fiscal year.
RTI Surgical Profile
RTI Surgical, Inc, together with its subsidiaries, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes. Receive News & Ratings for RTI Surgical analysts' ratings for RTI Surgical and related companies daily email newsletter .